Skip to content

Bark, Inc. BARK Concentration Risk %

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp

Segments

By segment

See full
Commerce:0%

Other financials

Income statement

See full
Revenue$86.6M-25.0%
Gross profit$54.3M-26.0%
Operating income-$12.2M-84.1%
Net income-$12.7M-109%
EPS (diluted)-$4.42-22.1%

Balance sheet

See full
Cash & equivalents$19.3M-80.2%
Total debt$37.7M-55.8%
Total equity$72.0M-27.6%
Total assets$170.0M-34.8%

Cash flow

See full
Operating cash flow-$1.4M+86.8%
CapEx$713.0K-58.8%
Free cash flow-$2.1M+82.8%

Valuation

See full
Market cap$87.75M-36.9%
Enterprise value$106.15M-22.1%
P/S0.2×-0.1×

Profitability

See full
Gross margin61.3%-1.1pp
Operating margin-10.2%+6.8pp
Net margin-9.9%+8.2pp
FCF margin-7.1%-18.9pp

Returns & leverage

See full
Return on equity-45.5%+85.4pp
Debt / equity0.5×-0.3×
Current ratio1.9×+0.2×